National Anti-epidemic Advanced Individualprofessor liu zhong and his party

Visit Sunway to promote strategic cooperation

In March of Yangchun, Jinling was full of flowers and colorful falls. In the most beautiful season, we welcomed Professor Liu Zhong and Dr. Li Ling, two anti-epidemic heroes from the Institute of Blood Transfusion of the Chinese Academy of Medical Sciences.On April 1, 2021, two experts came to Sunway Biology. The management team of Sunway Biology paid sincere tribute to the visit of the two heroes! For the two experts presented carefully prepared flowers to pay tribute to the hero! The two sides once again carried out technical integration and project extension exchange on the riboflavin pathogen inactivation project promoted by the strategic cooperation between the two sides, aiming to further deepen the strategic cooperation project between the two sides.

Since the outbreak of the novel coronavirus, the search for effective treatment has been the goal of clinicians and researchers. At the beginning of the epidemic, everything was still unknown,January 28, 2020 Professor Zhong Liu and Dr. Ling Li of the team shoulder the responsibility of scientific research workers, without hesitation.Went to Wuhan to join this unprecedentedin the "battle. This stay is a few months, in which they have experienced the fear of the unknown, the anxiety of helplessness, the pressure of technical research, and the pain of parting with their loved ones, but in the face of the challenge, overcoming the epidemic is the ultimate mission of their hearts, is to contribute to the country and the people their lifelong learning determination! It is because of these beliefs that Professor Liu Zhong's team is at the forefront of the epidemic.For the treatment of COVID-19 carried out"Clinical study of convalescent plasma for the treatment of severe patients with new crowns" has provided scientific and technological support for strengthening the prevention and control of the epidemic and the treatment of severe patients, saving the lives of many severe patients. The treatment quickly gained recognition in the professional field and was publicized and promoted in various news media.

Convalescent plasma therapy is a traditional blood transfusion therapy.In March 2020, Professor Zhong Liu was invited to present the Chinese experience at the International Symposium on Convalescent Plasma Therapy organized by the American Association for Therapeutic Aheresis (ASFA). On June 3, 2020, Professor Zhong Liu's team published a report on the convalescent plasma treatment of the new coronary pneumonia RCT study in JAMA. They have achieved significant results in RCT research and efficacy analysis around convalescent plasma therapy. With Yangchun Budeser, all things can shine! It is they who defend with science, wisdom, sweat and even life. In this battle, they have achieved impressive "results". They are well-deserved heroes in this battle! On September 8, 2020, Professor Liu Zhong was awarded the supreme honor "National Advanced Individual in the Fight against New Coronary Pneumonia" at the Great Hall of the People in Beijing ".

With the development of clinical medicine, blood transfusion treatment technology is also rapid progress, and has become one of the important means of clinical treatment of diseases, but blood transfusion can not only treat diseases, but also may cause adverse reactions. The likelihood of a recipient experiencing an adverse transfusion reaction is called transfusion risk. The risk of blood transfusion inIn October 2019, Shuangwei Biology and the Institute of Blood Transfusion of Chinese Medical College jointly launched the "Blood Pathogen Inactivation System Technology Achievement Transformation Project". Since the launch of the project, the two sides have carried out in-depth research in their respective areas of expertise, aiming to industrialize this globally recognized safe and effective inactivation technology to protect the safety of blood transfusion and treatment.

During the visit of the two experts, Sunway Biology and the expert team mainly carried out exchanges from two aspects. On the one hand, they communicated and summarized the research results of the existing strategic cooperation projects so far, and discussed the follow-up development work. A detailed action plan was discussed. Professor Liu Zhong's team carried out research on professional inactivation mechanism, covering liquid formulation, inactivation process, active ingredients, effect evaluation, etc. Sunway biological team mainly carried out specific work from the aspects of product design, process, transformation and final realization of marketing. on the other hand, the two sides had full exchanges on further strategic cooperation. In the future, the two sides hope to carry out diversified and in-depth cooperation on the basis of strategic cooperation. The Institute of Blood Transfusion is an authoritative institution in blood safety and blood treatment in China. They have top domestic scientific talents and high-end cutting-edge technology; Sunway Biology has also experienced in the field of safe blood transfusion in China.After 20 years of training, we have accumulated rich experience and have our own core technology. Through more integration of the two aspects, I believe we will be able to produce more emerging technologies and forces that promote the vigorous development of blood safety and medical care!